2025 Scrip Asia 100
Latest Updates And Considerations In Asia Pacific
Clinical Trials
Clinical trial activity is surging, driven by advancements in oncology and gene therapy. While approvals increase, delays in study initiation remain a critical hurdle for researchers in the region.
Beyond BIOSECURE: Lawmakers Flag US Clinical Trial Partnerships With Chinese Military Hospitals
Letter to US FDA by a bipartisan group of House members cites clinical trials sponsored by Eli Lilly and Pfizer as examples of a widespread industry practice. But any legislation to curtail such practices is not expected to be part of the BIOSECURE Act.
